• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

UrgentRx is reinventing pills

By
Matt Vella
Matt Vella
Down Arrow Button Icon
By
Matt Vella
Matt Vella
Down Arrow Button Icon
March 20, 2013, 11:21 AM ET

By Doron Levin, contributor

FORTUNE — Jordan Eisenberg, 31, was carrying a Benadryl around in his wallet back in 2009 when it dawned on him that he should find a better way to ensure his own safety in case of an allergy attack. He’s violently allergic to carrots, peanuts and many other fresh fruits and vegetables. “It’s unsanitary, the pills fall out and they disintegrate,” says Eisenberg, the chief executive officer of UrgentRx, his Denver, Colorado-based startup. His father and friends also carried aspirin in their wallets in the event of a heart attack.

His solution? Flavored powder in a credit card-sized, moisture-proof envelope. The powder comes close to emulating the taste of candy products like Pixy Stix. Creating a fruit-flavored powder that could deliver common over-the-counter medicines such as aspirin, calcium carbonate (for upset stomach) and diphenyldramine HCl (for allergy attacks) “wasn’t easy,” Eisenberg said. “Our drugs aren’t candy, it’s really hard to mask the taste of medicine through micro-encapsulation.”

Following its launch in January, UrgentRx powders have been sold in 3,000 stores nationwide. The goal is to get them into 25,000 stores, including such major chains as CVS (CVS). Each packet sells for a suggested retail price of $1.39.

MORE: Nobody needs an Apple iWatch—or anything like it

Eisenberg, a double major in engineering and mathematics from Vanderbilt University, originally worked as an investment banker before taking a job with the noted inventor and patent-holder, Maurice Kanbar. Kanbar created Skyy Vodka and other well-known products. “I always thought I wanted to be a venture capitalist,” says Eisenberg. “I came to understand that entrepreneurship is a rare commodity, it’s what I was meant to do.”

In the process of trying to raise investment capital, a mutual acquaintance introduced him to Randall Kaplan, a Los Angeles-based entrepreneur and investor who was a co-founder of Akamai Technologies (AKAM).

UrgentRx, with $5 million in funding, two years ago had a limited rollout to pharmacy chains and other retailers that sell remedies. “We made packaging and other changes,” Eisenberg said. “The feedback was incredibly important.” The company, which has eight employees, has just hired two vice presidents, one for sales and one for marketing.

MORE: How Rackspace is taking on Amazon now

Eisenberg’s hook is the claim that the company’s powdered aspirin, which it says acts faster than pills, has saved at least ten lives of people who swallowed UrgentRx when they were having a heart attack. Another plus, he says, is that the product is ideal for the estimated 6% of the population that is unable or has difficulty swallowing pills.

After investing in UrgentRx and becoming the company’s chairman, Kaplan is helping to raise another $2.5 million, which will be used in part to finance the marketing of the powders to more retailers. New investors include Sam Zell, the Chicago financier, actress Hillary Swank and Herb Simon, the shopping mall magnate.

UrgentRx follows on the heels of innovative delivery systems for medicinal products and caffeine, such as Vitamin Water and 5-Hour Energy Drink. The investors are hoping the packets will become a staple of home medicine cabinets—much like Alka Seltzer in the 1940s.

About the Author
By Matt Vella
See full bioRight Arrow Button Icon

Latest in

Middle EastMilitary
2 U.S. service members and one American civilian killed in Islamic State ambush in Syria, Central Command says
By Samar Kassabali, Bassem Mroue and The Associated PressDecember 13, 2025
19 minutes ago
InvestingStock
There have been head fakes before, but this time may be different as the latest stock rotation out of AI is just getting started, analysts say
By Jason MaDecember 13, 2025
32 minutes ago
Politicsdavid sacks
Can there be competency without conflict in Washington?
By Alyson ShontellDecember 13, 2025
1 hour ago
Investingspace
SpaceX sets $800 billion valuation, confirms 2026 IPO plans
By Loren Grush, Edward Ludlow and BloombergDecember 13, 2025
2 hours ago
PoliticsAffordable Care Act (ACA)
With just days to go before ACA subsidies expire, Congress is about to wrap up its work with no consensus solution in sight
By Kevin Freking, Lisa Mascaro and The Associated PressDecember 13, 2025
2 hours ago
PoliticsDonald Trump
Trump couldn’t insult his way to victory in Indiana redistricting battle. ‘Folks in our state don’t react well to being bullied’
By Thomas Beaumont, Isabella Volmert and The Associated PressDecember 13, 2025
3 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
23 hours ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
21 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.